1Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nommalignant hematologic diseases. Blood, 1998,91 :756-763.
2Georgs GE, Storb R, Thompson JD, et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloabhtive hematopoietic cell transplantation. Blood, 2000,95 : 3262-3269.
3Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood,2001,97 : 3380-3389.
4Savage WJ, Bleesing JJH, Douek D, et al. Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism. Bone Marrow Transplantation, 2001,28 : 463-471.
